STRATA Skin Sciences, Inc.
SSKN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -9.6% | 12.5% | -28.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 60.4% | 56.2% | 53.5% | 60.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2.5% | -9% | -9.4% | -29.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -23.4% | -32.5% | -35.7% | -47% |
| EPS Diluted | -0.36 | -0.6 | -0.058 | -0.12 |
| % Growth | 40% | -929.2% | 51.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |